As we have previously reported, thousands of lawsuits have been filed against Takeda Pharmaceutical Company for its medication Actos after studies revealed that diabetics taking the drug may be at an increased risk of developing bladder cancer. In 2011, the U.S. Food and Drug Administration (FDA) warned that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.

A plaintiff, alleging Actos caused his bladder cancer, was recently awarded $2.3 million in compensatory damages by a jury in Pennsylvania state court. The jury found that Takeda showed “reckless indifference” to the plaintiff’s health by hiding Actos’ risks and awarded another $1.3 million in punitive damages. There are approximately 8,000 other similar lawsuits currently pending in federal and state courts across the country.

If you believe you have experienced adverse side-effects from taking Actos, contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the manufacturers of Actos.